Matterhorn Biosciences Company
Matterhorn is a biotechnology company focusing on the discovery of cellular therapies targeting the MR1 molecule. MR1 presents cancer-specific metabolites on the surface of cancer cells that are recognized and killed by T cells bearing a MR1-specific T cell receptor.
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Employee Number:
11-50
Industry:
Cell, Gene & Biologics Therapeutics
Founded Date:
2020-01-01
Super Industry:
Biopharma & Life Science Tools
Investors:
Versant Ventures
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Alexander Flohr, Lucia Mori
